CD44 and breast carcinoma: CSCs have specific markers on their surface, along with general antigens and receptors (Walcher et al., 2020), which are organ‐specific, for example, CD44+/CD24 in breast cancer, CD133 in brain tumors, and epithelial‐specific antigens in pancreatic cancer.